Company Spotlight

Adare Pharmaceuticals

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile

Alcami

4620 Creekstone Drive
Durham, NC 27703
United States
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile


Contract Service Directory


Neuland Laboratories





Company Headquarters

Sanali Info Park, 'A' Block, 8-2-120/113, Road No.2, Banjara Hills
Hyderabad, AP 500034
India

Contract Service Directory

    Related Content

    • Breaking News | CRO News | Promotions & Moves
      Parexel Adds Experts to Regulatory Consulting Group

      Parexel Adds Experts to Regulatory Consulting Group

      Four new hires from U.S. FDA and MHRA will serve as technical vice presidents
      12.10.19

    • Breaking News | Drug Development | Trials & Filings
      SK Bio Gains FDA Approval for XCOPRI

      SK Bio Gains FDA Approval for XCOPRI

      Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval
      11.25.19

    • Cold Chain Management | Logistics | Serialization | Supply Chain

      Review of FDA DSCSA Guidance Documents

      Brian Daleiden of TraceLink reviews the latest requirements from the FDA and DSCSA


    • Breaking News | Facilities | Industry News
      Lilly to Invest $400M in Manufacturing Facilities

      Lilly to Invest $400M in Manufacturing Facilities

      Company to add approximately 100 jobs in Indianapolis expansion.
      11.22.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biopharma Over 20 Years

      Biopharma Over 20 Years

      A look at the key trends that have impacted the biopharma industry over the years.
      K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19

    • Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future

      Tuesday, November 5th, 1:30 PM - 2:30 PM   Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future Location: 214 CD Manufacturing and Bioprocessing – Chemical…
      10.28.19


    • APIs | cGMP Manufacture | Clinical Trial Materials | Custom Sourcing News | Industry News
      Nordic Nanovector, Isotope Technologies Enter Supply Pact

      Nordic Nanovector, Isotope Technologies Enter Supply Pact

      Extend global supply agreement for n.c.a. Lutetium-177 (EndolucinBeta)
      10.07.19

    • Biopharmaceuticals & Analytical Testing Technology

      Biopharmaceuticals & Analytical Testing Technology

      Analytical technology and processes are evolving as the biologics industry continues to grow.
      10.01.19

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      Continued and Consistent Investment in Manufacturing Facilities

      Continued and Consistent Investment in Manufacturing Facilities

      As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challenge
      Ryan Carpentier, Executive Director of Business Development, Cryoport 09.23.19


    • Regulatory Affairs
      Quality Metrics Feedback

      Quality Metrics Feedback

      A look at FDA’s Quality Metrics Initiative, a complicated issue for all of pharma stakeholders
      Gil Roth, President, Pharma & Biopharma Outsourcing Association 09.16.19

    • Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
      FDA Extends CRADA with CluePoints

      FDA Extends CRADA with CluePoints

      Aims to further explore a data-driven approach to quality oversight in clinical trials
      09.11.19

    • cGMP Manufacture | Collaborations & Alliances
      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      CRADA enables FDA and NIIMBL to support investments in regulatory science research, and training needed to foster advanced manufacturing innovations
      08.01.19


    • Trials & Filings
      FDA Accepts RedHill Biopharma’s NDA for Talicia

      FDA Accepts RedHill Biopharma’s NDA for Talicia

      Commercial launch of H. pylori treatment is planned shortly following potential FDA approval
      07.16.19

    • 02	Novartis

      02 Novartis

      Headquarters: Basel, Switzerland twitter.com/novartis www.novartis.com Headcount: 125,161 Year Established: 1996 Revenues:  $51,900  (+6%) Pharma Revenues:  $44,751  (+6%) Net Income:  $12,614  (+64%) R&D:  $…
      07.15.19

    • Risk-Based Monitoring

      Risk-Based Monitoring

      Leveraging intelligent analytics to realize the full value of RBx and compliance with ICH E6 (R2)
      Richard Davies, Vice President, Solution Expert, CluePoints 06.13.19

    • The Orphan Promise

      The Orphan Promise

      New policy on rare disease treatments likely soon
      S. Harachand, Contributing Editor 06.13.19